Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation - PubMed (original) (raw)
. 2000 Jun 16;275(24):18138-44.
doi: 10.1074/jbc.M000379200.
Affiliations
- PMID: 10747905
- DOI: 10.1074/jbc.M000379200
Free article
Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation
C F Terry et al. J Biol Chem. 2000.
Free article
Abstract
Interleukin 6 (IL6) plays key roles in hematopoiesis, immune, and acute phase responses. Dysregulated IL6 expression is implicated in diseases such as atherosclerosis and arthritis. We have examined the functional effect of four polymorphisms in the IL6 promoter (-597G-->A, -572G-->C, -373A(n)T(n), -174G-->C) by identifying the naturally occurring haplotypes and comparing their effects on reporter gene expression. The results indicate different transcriptional regulation in the ECV304 cell line compared with the HeLa cell line, suggesting cell type-specific regulation of IL6 expression. The haplotypes showed functional differences in the ECV304 cell line; transcription was higher from the GG9/11G haplotype and lower from the AG8/12G allele. The differences suggest that more than one of the polymorphic sites is functional; the base differences at distinct polymorphic sites do not act independently of one another, and one polymorphism influences the functional effect of variation at other polymorphic sites. These results show that genetic polymorphisms in the promoter influence IL6 transcription not by a simple additive mechanism but rather through complex interactions determined by the haplotype.
Similar articles
- Multiple levels of regulation of the interleukin-6 system in stroke.
Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, Schwaninger M. Acalovschi D, et al. Stroke. 2003 Aug;34(8):1864-9. doi: 10.1161/01.STR.0000079815.38626.44. Epub 2003 Jul 3. Stroke. 2003. PMID: 12843357 Clinical Trial. - Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R. Giacopelli F, et al. Physiol Genomics. 2004 Dec 15;20(1):87-96. doi: 10.1152/physiolgenomics.00138.2004. Epub 2004 Oct 12. Physiol Genomics. 2004. PMID: 15479859 - Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA, Muktanand T, Sankhwar SN, Goel A, Sankhwar PL, Rajender S. Gautam KA, et al. Cytokine. 2016 Jan;77:152-6. doi: 10.1016/j.cyto.2015.11.008. Epub 2015 Nov 19. Cytokine. 2016. PMID: 26605964 - The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism.
Villuendas G, San Millán JL, Sancho J, Escobar-Morreale HF. Villuendas G, et al. J Clin Endocrinol Metab. 2002 Mar;87(3):1134-41. doi: 10.1210/jcem.87.3.8309. J Clin Endocrinol Metab. 2002. PMID: 11889177 - Association between -174G/C and -572G/C interleukin 6 gene polymorphisms and severe radiographic damage to the hands of Mexican patients with rheumatoid arthritis: a preliminary report.
Zavaleta-Muñiz SA, Gonzalez-Lopez L, Murillo-Vazquez JD, Saldaña-Cruz AM, Vazquez-Villegas ML, Martín-Márquez BT, Vasquez-Jimenez JC, Sandoval-Garcia F, Ruiz-Padilla AJ, Fajardo-Robledo NS, Ponce-Guarneros JM, Rocha-Muñoz AD, Alcaraz-Lopez MF, Cardona-Müller D, Totsuka-Sutto SE, Rubio-Arellano ED, Gamez-Nava JI. Zavaleta-Muñiz SA, et al. Genet Mol Res. 2016 Dec 19;15(4). doi: 10.4238/gmr15049017. Genet Mol Res. 2016. PMID: 28002590
Cited by
- The role of interleukin-6 and interleukin-8 gene polymorphisms in non-alcoholic steatohepatitis.
Cengiz M, Yasar DG, Ergun MA, Akyol G, Ozenirler S. Cengiz M, et al. Hepat Mon. 2014 Dec 24;14(12):e24635. doi: 10.5812/hepatmon.24635. eCollection 2014 Dec. Hepat Mon. 2014. PMID: 25737730 Free PMC article. - Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility.
Al-Mohaya MA, Al-Otaibi L, Al-Harthi F, Al Bakr E, Arfin M, Al-Asmari A. Al-Mohaya MA, et al. BMC Oral Health. 2016 Aug 20;16(1):76. doi: 10.1186/s12903-016-0277-x. BMC Oral Health. 2016. PMID: 27544215 Free PMC article. - Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment.
Reale M, Costantini E, Greig NH. Reale M, et al. Front Psychiatry. 2021 Mar 5;12:536257. doi: 10.3389/fpsyt.2021.536257. eCollection 2021. Front Psychiatry. 2021. PMID: 33746786 Free PMC article. Review. - Effects of the IL6 -174G>C promoter polymorphism and IL-6 serum levels on the progression of cutaneous malignant melanoma.
Vlaykova T, Kurzawski M, Tacheva T, Dimov D, Anastasov A, Vlaykova D, Miteva A, O'donoghue N, Drozdzik M. Vlaykova T, et al. Oncol Lett. 2020 Aug;20(2):1781-1791. doi: 10.3892/ol.2020.11740. Epub 2020 Jun 16. Oncol Lett. 2020. PMID: 32724421 Free PMC article. - Uncovering Outcome Disparities of β2 Adrenergic Agonists in Blacks: A Systematic Review.
Jerome RN, Pulley JM, Sathe NA, Krishnaswami S, Dickerson AB, Worley KJ, Lima MF, Wilkins CH. Jerome RN, et al. J Natl Med Assoc. 2021 Feb;113(1):8-29. doi: 10.1016/j.jnma.2020.07.001. Epub 2020 Jul 28. J Natl Med Assoc. 2021. PMID: 32732018 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources